Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01866917 · ClinicalTrials.gov registry record · Phase 1
Study of TAP and Laparoscopic and Robotic Gynecologic Procedures and Obese Women
A Phase 1 study, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
NCT01866917: Clinical Trial Phase 1 study, sponsored by Montefiore Medical Center.
NCT01866917 is a Phase 1 study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 35 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01866917, a Phase 1 study, was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
Study Summary
Study the effect of the Transversis Abdominis Plane (TAP) block on pain after surgery for obese women undergoing laparoscopic or robotic gynecologic procedures.
Primary Outcome
Pain assessments by verbal numerical pain score (NPS) at 0, 1 and 2 hours prior to discharge in the Post Anesthesia Care Unit. The 10 point NPS scale ranges from 0-10 with 0 being equivalent to no pain and a value of 10 being equivalent to the worst pain imaginable
Interventions
- DRUG Placebo
- DRUG Ropivacaine 0.5% 20cc injectate bilaterally
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2013-04 |
| Est. Completion | 2016-04 |
| Phase | Phase 1 |
Why NCT01866917 stopped before completion
NCT01866917 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (42% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01866917 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01866917 about?
NCT01866917 is a clinical study titled "Study of TAP and Laparoscopic and Robotic Gynecologic Procedures and Obese Women". Study the effect of the Transversis Abdominis Plane (TAP) block on pain after surgery for obese women undergoing laparoscopic or robotic gynecologic procedures.
What is the current status of trial NCT01866917?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2013-04. Estimated completion is 2016-04.
What interventions are being tested in trial NCT01866917?
The interventions under investigation include: Placebo (DRUG), Ropivacaine 0.5% 20cc injectate bilaterally (DRUG).
Who is sponsoring clinical trial NCT01866917?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01866917's enrollment target sits among peer trials
35 1258th of 2000 higher than 728 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia